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Alexander’s disease (AD) is a rare neurodegenerative dis-
order, classified as a leukodystrophy and characterized by 
macrocephaly, psychomotor regression, spasticity, ataxia, and 
seizures1. Neuropathologically, it is diagnosed by the presence 
of perivascular, periventricular, brainstem, and cerebellar eo-
sinophylic intra-astrocytic cytoplasmic inclusions, which are 
called Rosenthal fibres1. AD is caused by mutations in the 
gene encoding glial fibrillary acidic protein (GFAP) on chro-
mosome 17qq21, with an autosomal dominant inheritance1-3. 
The aim was to describe a female young patient with progres-
sive cerebellar ataxia as the first manifestation of AD. 
A 13-year-old female was investigated because of a four-
year history of progressive gait disorder and incoordina-
tion. These progressive symptoms were accompanied by 
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dysarthria, poor balance, and poor academic performance. 
Neurological examination showed mild cognitive impair-
ment (MMSE=20), dysarthria, horizontal and vertical gaze-
evoked nystagmus, and gait ataxia. Brain magnetic resonance 
image (MRI) showed bilateral symmetric leukoencephalopa-
thy, with frontal preponderance, without signal changes in 
the cerebellum (Figure). The patient was evaluated in another 
neurological service and she had an extensive work up, in-
cluding anti-gliadin, anti-peroxidase, anti-thyroglobulin, and 
anti-GAD antibodies, spinal cord MRI, electroneuromyogra-
phy, sural nerve biopsy, and tests for inherited metabolic dis-
orders, including very long-chain fatty acid, arysulfatase A 
and beta-galactosidase activity test. These were all normal. 
Re-evaluation of brain MRI suggested the diagnosis of AD. 
Molecular genetic test confirmed a heterozygous mutation 
(D157N) in the exons 2 and 8 (M4151) in the GFAP gene. The 
patien’s mother was diagnosed with multiple sclerosis, treat-
ed with steroids and interferon. She had cerebellar ataxia and 
spasticity in the legs, and the brain MRI showed white matter 
abnormalities predominantly in both frontal lobes. She has 
a heterozygous mutation (M4151) in the exon 8 in the GFAP 
gene, confirming that she also had AD. 
AD is divided into three different forms: typical infantile 
form, with onset before two years of age and rapidly lethal 
course; juvenile form, with onset between 2 and 12 years of 
age, with slower progression; adult-onset form, with onset af-
ter the age of 12 years, or during adulthood, with predomi-
nant involvement of the brainstem, with bulbar or pseudob-
ulbar symptoms, such as dysarthria, dysphagia, pyramidal 
signs, palatal myoclonus, and cerebellar ataxia1. 
MRI in early onset of AD is characterized by supratentori-
al periventricular white matter abnormalities, particularly in 
the frontal lobes. In adult-onset cases, MRI is often character-
ized by atrophy and signal abnormalities in the medulla ob-
longata and upper spinal cord1,3. Juvenile AD represents 17.8 
to 24.2% of the total cases, and it is the least common form 
of the disease. It represents a continuum between the infan-
tile form, with cortical and subcortical signs, and the adult 
one with cerebellar and brainstem signs1,4. Yoshida et al.4 pro-
posed a new clinical guideline for diagnosis of AD, including 
AD type 1, or cerebral AD, type 2, or bulbospinal AD, and type 
3 or intermediate form of AD. This should be included in the 
differential diagnosis of cerebellar ataxia, with early and late 
onsets, in sporadic and hereditary cases1,5. Delnooz et al.5 de-
scribed two sibs with AD, hereditary late-onset ataxia, and 
only minimal white matter changes. The phenotypic spec-
trum of AD was enlarged after the definition of the molecular 
genetic diagnosis with GFAP analysis1-5.
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Figure. Brain magnetic resonance image of patient affected by 
Alexander’s disease performed at age of 13. The images show 
bilateral and symmetrical hyperintensities on T2-wheighted 
in white matter, with frontal predominance suggestive of the 
diagnosis. 
